In addition to optic neuropathy, more than 20% of patients with OPA1 mutations manifest neurodegenerative problems such as ptosis, ataxia, peripheral neuropathy, mitochondrial myopathy, and progressive external opthalmoplegia as well as bilateral sensorineural hearing loss [18,19,20,21]. This evidence concerns the gene OPA1 and Optic neuropathy.